Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2014 Jul 31;13(10):2303–2314. doi: 10.1158/1535-7163.MCT-13-1005

Figure 1.

Figure 1

ICG-001 inhibits in vitro anchorage dependent and independent growth of pancreatic cancer lines. (A) Chemical structure of ICG-001. (B) MTT cell viability and (C) soft agar assays were performed at the indicated concentrations of ICG-001. (D) MTT assay on AsPC-1 cells treated for 6 days with vehicle (V), 5 μM ICG-001 (I), 5 nM gemcitabine (G) or 5 μM ICG-001 plus 5 nM gemcitabine (I+G). Representative experiment from at least three replicates is presented for each cell line. *P<0.05, **P<0.01, ***P<0.001, n=not significant.